683 Capital Management »

Zura Bio shares owned by 683 Capital Management

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 259k 5.24

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Zura Bio

Suvretta Capital Management
VR Adviser
Jpmorgan Chase & Co
Dr. Jeffrey R. Jay, M.D.
Braidwell
Adage Capital Partners GP
Pfizer
Affinity Asset Advisors
Armistice Capital
Siren
Marshall Wace
Ikarian Capital
Jane Street
Millennium Management
Vanguard Group

View all funds holding Zura Bio